CORDIS Project
Funding breakdown and partner intelligence are Premium
Sign in and upgrade to Premium for EU contribution totals, consortium analytics, OpenAlex research context, and AI summaries. · 0 consortium intelligence fields visible of 1
Start free • Cancel anytime • 14-day refund guarantee
Stemmatters is developing a platform technology for cell and gene therapies that enhances cell retention and function through encapsulation. This innovation aims to improve clinical outcomes and reduce costs in various therapeutic applications.
Cell and gene therapies holds tremendous therapeutic promise for patients worldwide and represent a valuable global market opportunity.
Still, cell-based therapies present challenges related chiefly to cell retention, engraftment and survival.
Minimally invasive cell delivery and improved retention by means of an encapsulation technology is a driver for generating more predictable clinical outcomes with lesser immune rejection in a variety of disease areas.
Stemmatters has built a highly versati…
STEMMATTERS, BIOTECNOLOGIA E MEDICIINA REGENERATIVA SA
Partner organizations (coordinator is shown above), with normalized type and CORDIS activity type. Guests see up to 4 partners.
Similar projects, consortium collaboration history, frequent partners, and OpenAlex research context.
Guests see up to 5 EuroSciVoc fields.
Guests see up to 5 topics.
Guests see up to 5 keywords.
